The Lenovo Yoga Slim 7i 15 Aura Edition is a slim and gorgeous laptop that's let down only by its dodgy Lunar Lake processor.

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...

Lenovo is one of the most popular and enduring laptop brands in the world—and with good reason, with powerful performance and long battery life in a compact, lightweight package across a range ...

It won’t come as a huge surprise, but the Lenovo Legion Go 2 is confirmed as being in development, although the name is subject to change. Lenovo’s gaming category manager for the APAC region ...

The Danish drug company Novo Nordisk has been sanctioned by the UK pharmaceutical industry regulator over the way it has promoted its weight loss medications semaglutide (Ozempic/Wegovy) and ...

or anyone who likes to wear yoga pants as regular pants. On this list, you’ll find pants that can stash your AirPods and phone, pants with a smaller waistband pocket for your apartment key, and ...

The Lenovo and Yoga logos have a polished finish that adds an elevated touch to the basic design. Inside is a gray keyboard with thin white legends, row of function keys, and top-firing speakers.

Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according to new research that adds to the evidence surrounding the drug’s ...

Yoga can be a valuable tool for managing menopause symptoms, offering physical relief and emotional balance through mindful movement and breathing techniques. Share on Pinterest The Good Brigade ...

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...

Denmark unveiled an Nvidia-powered supercomputer that will be used by researchers from Novo Nordisk A/S and other Danish pharmaceutical companies as they seek novel drugs and smarter trial designs.